June 06, 2015
Researchers at Novartis recently published a study using a lentiviral based library containing many millions of unique sequences (barcodes) to label and track erlotinib-resistant non-small lung cancer cells. The approach provided a way to differentiate whether these resistant cells were already present in...
Read More